Key Points
- Glenbrook Capital Management increased its Senestech stake by purchasing 181,252 shares at an average of $0.63, worth approximately $114,189. The transaction raised its direct ownership by 12.04% to 1.69 million shares.
- Senestech shares opened at $0.70 and were reported up 8.2%, but remain near the lower end of their 52-week range of $0.55 to $4.04. The company reported better-than-expected quarterly results, with a $0.35 per-share loss and $0.77 million in revenue.
- Analyst sentiment remains negative: Weiss Ratings downgraded the stock to “sell,” and the average analyst rating is “Sell.” Senestech is forecast to post a $1.28 per-share loss for the current year.
Senestech, Inc. (NASDAQ:SNES - Get Free Report) major shareholder Glenbrook Capital Management acquired 181,252 shares of the business's stock in a transaction on Friday, October 16th. The stock was bought at an average cost of $0.63 per share, for a total transaction of $114,188.76. Following the completion of the transaction, the insider directly owned 1,686,546 shares of the company's stock, valued at $1,062,523.98. This trade represents a 12.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Monday, October 19th, Glenbrook Capital Management acquired 376,552 shares of Senestech stock. The shares were bought at an average price of $0.70 per share, for a total transaction of $263,586.40.
- On Thursday, October 15th, Glenbrook Capital Management bought 426,000 shares of Senestech stock. The stock was bought at an average cost of $0.77 per share, with a total value of $328,020.00.
- On Friday, August 7th, Glenbrook Capital Management bought 6,490 shares of Senestech stock. The stock was bought at an average cost of $1.30 per share, with a total value of $8,437.00.
- On Thursday, August 6th, Glenbrook Capital Management bought 15,000 shares of Senestech stock. The stock was bought at an average price of $1.30 per share, with a total value of $19,500.00.
Senestech Trading Up 8.2%
SNES stock opened at $0.70 on Tuesday. The company has a current ratio of 6.78, a quick ratio of 5.81 and a debt-to-equity ratio of 0.02. Senestech, Inc. has a 1 year low of $0.55 and a 1 year high of $4.04. The stock has a 50-day simple moving average of $0.92 and a 200-day simple moving average of $1.34.
Senestech (NASDAQ:SNES - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.37) by $0.02. The firm had revenue of $0.77 million for the quarter, compared to analyst estimates of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. Sell-side analysts forecast that Senestech, Inc. will post -1.28 EPS for the current year.
Institutional Investors Weigh In On Senestech
An institutional investor recently bought a new position in Senestech stock. Diversify Wealth Management LLC acquired a new position in Senestech, Inc. (NASDAQ:SNES - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The fund acquired 19,119 shares of the company's stock, valued at approximately $31,000. Diversify Wealth Management LLC owned approximately 0.36% of Senestech at the end of the most recent reporting period. Institutional investors own 5.19% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings lowered shares of Senestech from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock currently has an average rating of "Sell".
View Our Latest Research Report on Senestech
Senestech Company Profile
(
Get Free Report)
SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company's approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.
SenesTech's primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
